Predicting the risk of hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral therapy: Validating the CAMD and AASL scores in China
Conclusions: Both CAMD and AASL scores have predictive value for HCC risk of CHB patients in Northeast China. In future, the optimal monitoring frequency and methods should be personalized.
Source: The Saudi Journal of Gastroenterology - Category: Gastroenterology Authors: Shuai Wang Bingwei Liu Xuemei Fan Yang Gao Mingqi Hong Yan Xu Source Type: research
More News: Antiviral Therapy | Cancer & Oncology | Carcinoma | China Health | Cirrhosis | Diabetes | Endocrinology | Gastroenterology | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Japan Health | Liver | Liver Cancer | Middle East Health | Saudi Arabia Health | Urology & Nephrology